Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A new study has attempted to calculate the impact of age, health status, and patient preference on the relative outcomes (and merits) of immediate surgery as compared to active surveillance for the management of low-risk prostate cancer.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, life, low, outcome, quality, risk, surgery | 3 Comments »
The “New” Prostate Cancer InfoLink is delighted to see the early results of a major study conducted by the National Bureau of Economic Research which has effectively proven that patients on Medicaid find regular doctors, see those doctors more often, feel better, are less depressed, and are better able to maintain financial stability than those [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: health care, Medicaid, quality, uninsured | 2 Comments »
Craig Turner, MD, practices urology in Portland, Oregon, and for the past 6 years or so he has been carrying out laparoscopic radical prostatectomies with the help of a da Vinci robot … but he doesn’t seem to think this has made him a better prostate cancer surgeon.
Filed under: Management, Treatment | Tagged: care, economics, outcome, quality, RALP, technology | 1 Comment »
Barocas and Penson have offered a helpful new review of racial variation in the patterns and the quality of care offered to prostate cancer patients in the USA. The entire paper is available on line through the UroToday web site.
Filed under: Living with Prostate Cancer, Management | Tagged: care, pattern, quality, race, variation | Leave a Comment »
The October issue of the Journal of Urology carries three editorials that we consider to be very important to the world of prostate cancer — for professionals and patients alike.
Filed under: Diagnosis, Management, Treatment | Tagged: active, outcomes, quality, risk, surgery, surveillance | 3 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site